Home › NDC Lookup › RxCUI directory › RxCUI 104232

Spironolactone 5 MG/ML Oral Suspension — RxCUI 104232

RxNorm drug concept · Semantic clinical drug
RxCUI 104232 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 16 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI104232
Official nameSpironolactone 5 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asspironolactone 25 MG per 5 ML Oral Suspension; spironolactone 25 MG in 5 mL Oral Suspension
FDA products mapped5
Package NDCs mapped16
Reported Medicaid activity (SDUD)16,025 prescriptions · 43 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Spironolactone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Spironolactone has a few different uses depending on your situation. Most commonly, it's prescribed to treat moderate-to-severe heart failure, high blood pressure, or fluid buildup...
  • What exactly is spironolactone used for?
  • Yes, it actually matters quite a bit. Food can nearly double the amount of spironolactone your body absorbs. That doesn't mean you must always take it with food — but you should pi...
  • Does it matter if I take it with food or not?
📖 Read our full Spironolactone guide →

🕸️ Concept Web — How Spironolactone 5 MG/ML Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Spironolactone 5 MG/ML Oral Suspension RxCUI 104232

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Spironolactone 9997
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Carospir 1943340
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Spironolactone Oral Suspension 379251
    • Spironolactone Oral Liquid Product 1161121
    • Spironolactone Oral Product 1161122
    • Spironolactone Oral Suspension [Carospir] 1943342
    • Carospir Oral Liquid Product 1943343
    • Carospir Oral Product 1943344
    • Oral Suspension 316969
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Spironolactone 5 MG/ML 360520
    • Spironolactone 5 MG/ML Oral Suspension [Carospir] 1943345
    • Spironolactone 5 MG/ML [Carospir] 1943341

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Spironolactone 5 MG/ML SCDC · 360520
  • Spironolactone Oral Suspension SCDF · 379251
  • Spironolactone Oral Liquid Product SCDG · 1161121
  • Spironolactone Oral Product SCDG · 1161122

Brand-Name Concepts

  • Spironolactone 5 MG/ML Oral Suspension [Carospir] SBD · 1943345
  • Spironolactone 5 MG/ML [Carospir] SBDC · 1943341
  • Spironolactone Oral Suspension [Carospir] SBDF · 1943342
  • Carospir Oral Liquid Product SBDG · 1943343
  • Carospir Oral Product SBDG · 1943344
  • Carospir BN · 1943340

📦 FDA Products & Package NDCs

5 products · 16 package NDCs
16 package NDCs map to RxCUI 104232 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00574-1133-04 118 mL in 1 BOTTLE (0574-1133-04) SPIRONOLACTONE Padagis US LLC 2023-10-31
00574-1133-10 10 CUP, UNIT-DOSE in 1 CARTON (0574-1133-10) / 5 mL in 1 CU... SPIRONOLACTONE Padagis US LLC 2023-10-31
00574-1133-16 473 mL in 1 BOTTLE (0574-1133-16) SPIRONOLACTONE Padagis US LLC 2023-10-31
17856-1133-01 1 SYRINGE in 1 BAG (17856-1133-1) / 2.5 mL in 1 SYRINGE SPIRONOLACTONE ATLANTIC BIOLOGICALS CORP. 2024-06-03
17856-1133-04 1 SYRINGE in 1 BAG (17856-1133-4) / 2.5 mL in 1 SYRINGE SPIRONOLACTONE ATLANTIC BIOLOGICALS CORP. 2025-09-26
17856-1133-05 120 SYRINGE in 1 CASE (17856-1133-5) / 1 mL in 1 SYRINGE SPIRONOLACTONE ATLANTIC BIOLOGICALS CORP. 2026-04-30
17856-1133-06 120 SYRINGE in 1 CASE (17856-1133-6) / 3 mL in 1 SYRINGE SPIRONOLACTONE ATLANTIC BIOLOGICALS CORP. 2026-04-30
17856-1133-07 1 SYRINGE in 1 BAG (17856-1133-7) / 1 mL in 1 SYRINGE SPIRONOLACTONE ATLANTIC BIOLOGICALS CORP. 2026-07-02
17856-1133-08 1 SYRINGE in 1 BAG (17856-1133-8) / 3 mL in 1 SYRINGE SPIRONOLACTONE ATLANTIC BIOLOGICALS CORP. 2026-07-02
31722-0691-11 118 mL in 1 BOTTLE (31722-691-11) spironolactone Camber Pharmaceuticals, Inc. 2025-02-21
31722-0691-47 473 mL in 1 BOTTLE (31722-691-47) spironolactone Camber Pharmaceuticals, Inc. 2025-02-21
46287-0020-01 473 mL in 1 BOTTLE (46287-020-01) CaroSpir CMP Pharma, Inc. 2017-08-04
46287-0020-04 118 mL in 1 BOTTLE (46287-020-04) CaroSpir CMP Pharma, Inc. 2017-08-04
46287-0020-50 10 CUP, UNIT-DOSE in 1 CARTON (46287-020-50) / 5 mL in 1 CU... CaroSpir CMP Pharma, Inc. 2021-07-15
69238-2027-02 473 mL in 1 BOTTLE (69238-2027-2) Spironolactone Amneal Pharmaceuticals NY LLC 2023-09-08
69238-2027-08 118 mL in 1 BOTTLE (69238-2027-8) Spironolactone Amneal Pharmaceuticals NY LLC 2023-09-08
Observed labelers: ATLANTIC BIOLOGICALS CORP. (6) · CMP Pharma, Inc. (3) · Padagis US LLC (3) · Amneal Pharmaceuticals NY LLC (2) · Camber Pharmaceuticals, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$1.7700
Range $1.5537–$3.4521 · middle 50% $1.5537–$1.7700 · 7 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.